View in EDS

Cost-effectiveness of omadacycline versus moxifloxacin as the initial treatment for community-acquired bacterial pneumonia in China.

Saved in:
Bibliographic Details
Title: Cost-effectiveness of omadacycline versus moxifloxacin as the initial treatment for community-acquired bacterial pneumonia in China.
Authors: Wang X; Department of Pharmacy Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatric Metabolism and Infllammatory Diseases, Chongqing, China, Chongqing, China., Fu Y; Department of Pharmacy Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatric Metabolism and Infllammatory Diseases, Chongqing, China, Chongqing, China., Duan G; Department of Pharmacy Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatric Metabolism and Infllammatory Diseases, Chongqing, China, Chongqing, China., Kong W; Department of Pharmacy, Zi Gong First People's Hospital, Shangyi Haoyi Branch Road, Ziliujing District, Zigong, 643000, Sichuan, China. WQkongpharmacist@outlook.com.
Source: International journal of clinical pharmacy [Int J Clin Pharm] 2026 Feb; Vol. 48 (1), pp. 257-265. Date of Electronic Publication: 2025 Nov 12.
Publication Type: Journal Article; Comparative Study
Journal Info: Publisher: Springer Country of Publication: Netherlands NLM ID: 101554912 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2210-7711 (Electronic) NLM ISO Abbreviation: Int J Clin Pharm Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2210-7711
DOI:10.1007/s11096-025-02048-1